Skip to content
National Centre for Pharmacoeconomics

National Centre for Pharmacoeconomics

NCPE Ireland

  • Home
  • Who We Are
    • About Us
    • Current Vacancies
    • Glossary
Register for NCPE Events
  • Who We Are
    • Meet The Team
    • Current Vacancies
    • Monthly Updates
    • Contact Us
    • Glossary
  • Submission
    Process
    • Overview of the Drug Reimbursement Process
    • NCPE Recommendations
    • Process Flowchart
    • HTA Guidelines
    • Pre-submission meetings
    • Submission Templates
      • Rapid Review Template
      • Budget Impact Model Template
      • Full HTA Submission Template
      • New Medicine Horizon Scanning Template
  • Patients & Healthcare
    Professionals
    • Patients
      • Patient Submission Process Overview
      • Template, Registration form, Guidelines and Tip Sheet
      • Interpreting NCPE Recommendations
      • Patient Education
      • Useful Links
      • Glossary of Terms
    • Healthcare Professionals
  • International
    Collaborations
    • European Union HTA Regulation
      • EUnetHTA21
    • International Horizon Scanning Initiative
    • Beneluxa Initiative
    • Heads of Agency Group
    • Other collaborations
  • Research &
    Education
    • Research
      • Research Themes
      • Peer-Reviewed Publications
      • Conference Abstracts
      • Covid 19 Evidence Reviews
    • Education
  • Drugs
  • Other Technologies

Amivantamab + lazertinib 25006 Plain English Summary

Amivantamab + lazertinib 25006 Plain English Summary

Post navigation

Previous

Archives

Date Archives2

  • Terms & Conditions
  • Privacy Policy
  • Cookies Policy
  • Contact Us
© National Centre for Pharmacoeconomics, Ireland
  • LinkedIn
  • X
National Centre for Pharmacoeconomics, St James's Hospital, Emmet House, 138-140 Thomas St, Dublin 8, Ireland. D08 XN61